IB

Ira Bhattacharya

Active Director Director DIN 11560907
DIN 11560907 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ira Bhattacharya

Data last updated:

Ira Bhattacharya is a Director at Efexgene Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11560907
Primary Designation Director
Industry Pharma
First Appointment 20 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Feb 20262026Active

Board colleagues of Ira Bhattacharya

NameDINCompanyDesignation
Arindam Bhattacharya08016432Efexgene Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Efexgene Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ira Bhattacharya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ira Bhattacharya

Ira Bhattacharya currently holds 1 directorship: Efexgene Pharmaceuticals Private Limited (Director, since 20 Feb 2026).

Ira Bhattacharya was first appointed on 20 Feb 2026 as Director at Efexgene Pharmaceuticals Private Limited.

The current boards of Ira Bhattacharya's companies include Arindam Bhattacharya (Efexgene Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available